Trichostatin A, suberoylanilide hydroxamic acid, M344 (an analogue of hydroxamic acid), and cyclic tetrapeptide are potent HDAC inhibitors that have been reported to promote radiosensitivity in head and neck tumours (110). This evidence concerns the gene HDAC9 and head and neck neoplasm.